News
("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeting and the launch meeting of YSJA™ rabies vaccine (Vero cell) novel ...
researchers working on interventions against those major pathogens use monkey cells, namely, the Vero cell. However, these cells have a low sensitivity to infection and limited distribution.
On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeting and the launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback